CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Agoraphobia

Obsessive, persistent, intense fear of places or situations from which escape might be difficult or embarrassing.

Drugs by status

Phase 4 trials (5)

  • paroxetine
  • clonazepam
  • methylphenidate
  • escitalopram
  • sertraline

Phase 3 trials (3)

  • cannabidiol
  • sunflower oil
  • tetrahydrocannabinol

Phase 2 trials (1)

  • cycloserine

Organizations

Organization Involved with Phase 4 Indications (8)

  • Pfizer
  • Purdue Pharmaceuticals
  • Hamilton Health Sciences Corporation
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Georgetown University
  • McMaster University
  • Federal University of Rio de Janeiro
  • Patient-Centered Outcomes Research Institute

Organization Involved with Phase 3 Indications (6)

  • Tilray
  • National Institute of Mental Health (NIMH)
  • University of Pittsburgh
  • Boston University
  • Yale University
  • Columbia University

Organization Involved with Phase 2 Indications (2)

  • Humboldt University
  • German Federal Ministry of Education and Research

ICD-10 crosswalk

  • F40.00 — Agoraphobia, unspecified

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.